PHR Net Income Growth
Period ending:
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
PHR net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Jan 31, 2020 to Jul 31, 2026.
| Period ending | Net Income Growth |
|---|---|
| 143.4333% | |
| 121.4963% | |
| 103.9401% | |
| 93.5023% | |
| 76.024% | |
| 64.1246% | |
| 57.2437% | |
| 42.6154% | |
| 34.2097% | |
| 26.6931% | |
| 22.2889% | |
| 21.8425% | |
| 15.638% | |
| -2.5286% | |
| -49.0729% | |
| -131.2809% | |
| -260.236% | |
| -392.7194% | |
| -332.951% | |
| -249.0465% | |
| -169.9376% | |
| -63.1355% | |
| -34.4923% | |
| -5.3465% | |
| 20.695% | |
| -6.3533% | |
| -34.7318% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All PHR financial metrics · PHR stock overview · How to interpret financial metrics